State-of-the-Art Paper
Randomized Clinical Trials and Observational Studies: Guidelines for Assessing Respective Strengths and Limitations

https://doi.org/10.1016/j.jcin.2008.01.008Get rights and content
Under an Elsevier user license
open archive

The 2 primary types of studies that are used to test new drugs or procedures or compare competing drugs or types of procedures are randomized clinical trials (RCTs) and observational studies (OS). Although it would appear that RCTs always trump OS because they eliminate selection bias, there are many possible limitations to both types of studies, and these limitations must be carefully assessed when comparing the results of RCTs and OS. This state-of-the art review describes these limitations and discusses how to assess the validity of RCTs and OS that yield different conclusions regarding the relative merit of competing treatments/interventions.

Abbreviations and Acronyms

BMS
bare-metal stent(s)
CABG
coronary artery bypass graft
CI
confidence interval
DES
drug-eluting stent(s)
HRT
hormone replacement therapy
OR
odds ratio
OS
observational study/studies
PES
paclitaxel-eluting stent(s)
PTCA
percutaneous translumincal coronary angioplasty
RCT
randomized controlled trial(s)
RR
relative risk

Cited by (0)